TRAINING
FORESIGHT TRAINING COURSES
We annually promote and organise the Foresight Training Courses (FTCs), short international courses aimed at training high-specialized professional profiles in the different fields of regulatory sciences.
The FTCs aim to deepen and disseminate regulatory innovations for the development and marketing of drugs and other innovative health products at European level, but also to encourage the involvement of the main stakeholders (regulatory experts from Agencies and industries, patients, healthcare professionals, non-profit organisations and researchers from academia) at all stages of the development of products for human health.
Archive Foresight
XVIII Foresight Training Course – 2026
ETHICS, GENDER, REGULATION AND USE OF DATA An interdisciplinary training school for inclusive...
XVII Foresight Training Course – 2025
FROM RESEARCH TO ACCESS: HOW DOES EUROPE SPEED UP THE AVAILABILITY OF MEDICINES FOR UNMET NEEDS?
XVI Foresight Training Course – 2023
Repurposing to cover unmet needs: the current scenario in Europe and the proposed changes to the pharmaceutical legislation
XV Foresight Training Course – 2022
Boosting research and innovation in a changing regulatory framework
XIV Foresight Training Course – 2021
The health emergency: regulatory crash and future perspectives
XIII Foresight Training Course – 2020
Challenges for researchers and regulators facing the pandemic crisis
XII Foresight Training Course – 2019
Innovative medicine and research: ethical, legal and regulatory issues
XI Foresight Training Course – 2018
Change in Regulatory Sciences in the EU – How to move from a reactive to a multi-stakeholders proactive attitude
X Foresight Training Course – 2017
The European Medicines Rregulatory Network: present and future
IX Foresight Training Course – 2016
Europe leads the best medicines system for patients
VIII Foresight Training Course – 2015
Regulatory and practice in paediatric trials and studies
VII Foresight Training Course – 2014
Halth and biotechnology
VI Foresight Training Course – 2013
Biotech and innovative science to meet patient needs
V Foresight Training Course – 2012
Science, regulation and business in pharmacotherapies: how to solve conflicts and exploit synergies for the benefit of patients
IV Foresight Training Course – 2011
Evidences for rational therapies: from newborn to elderly population
III Foresight Training Course – 2010
Benefit/risk assessment of medicines to achieve shared objectives: from research to reality
II Foresight Training Course – 2009
Advanced therapies and orphan drugs
I Foresight Training Course – 2008
European centralised procedure and paediatric regulation